AstraZeneca sends legal notice to Serum Institute, Poonawala seeks government help


AstraZeneca has sent a legal notice to the Serum Institute of India (SII) for the delay in the supply of the Corona vaccine. SII has therefore sought help from the Government of India in the form of a grant to double the production of Kovsheild. The Serona vaccine, developed by Oxford-AstraZeneca, is made and sold in India with the Covishield brand name in India. SII CEO Adar Poonawala said on Tuesday that about Rs 3,000 crore would be needed to increase the production capacity of the Kovid-19 vaccine.


“We need roughly Rs 3,000 crore, which is not a small figure because we have already spent thousands of crores of rupees,” Poonawalla told a TV channel. We have to find other new ways to build our capacity. ‘ He said that the company expects the production capacity of the Kovishield vaccine to increase to 11 crore per month from June.

Poonawala said that the company is producing 20 lakh doses per day. “We have given more than 100 million doses in India alone and exported around 60 million doses to other countries,” he said. The serum institute as well as other vaccine producers have also agreed with the government for not taking profits.

He said that no other vaccine company in the world is providing vaccines at such reduced prices. Poonawala said in another interview that the Serum Institute is prioritizing India’s temporary needs over others. The company is currently producing six to seven crore vaccines per month.




We will be happy to hear your thoughts

Leave a Reply

NewsTree News - Latest News For You.